Abstract
Infections are an important cause of morbidity and mortality in chronic, particularly end stage, renal disease. Uremia and dialysis are associated with immune impairment at multiple levels: decreased innate and adaptive immunity, increased inflammation. The role of vitamin D in the regulation of immune functions, particularly as an enhancer of innate immunity and as an anti-inflammatory agent, is now well recognized. Since vitamin D deficiency is frequent in patients with chronic kidney disease, several studies examined the relationships between vitamin D insufficiency and immune impairment or infectious diseases in this population. Vitamin D deficiency could contribute to decreased innate immunity and increased inflammation or immune cell activation, including through modulating the microbiome and intestinal permeability. Convincing data from epidemiological studies have associated vitamin D deficiency with inflammation, all-cause mortality, cardiovascular and infectious outcomes. However, intervention studies are still needed to validate the causality relationship and determine whether vitamin D supplementation can reduce infections in chronic kidney disease patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ralph AR, Lucas RM, Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis. 2013;13:77–88.
Ginde AA, Mansbach JM, Camargo Jr CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–90.
Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013;8(6):e65835. doi:10.1371/journal.pone.0065835.
Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1487–93. doi:10.2215/CJN.01290308.
Contu D, d’Ythurbide G, Messka J, et al. J Infect. 2014;68(2):105–15. doi:10.1016/j.jinf.2013.10.003.
Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83:1010–6. doi:10.1038/ki.2012.440.
Collins AJ, Foley RN, Gilbertson DT, et al. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl. 2015;5:2–7. doi:10.1038/kisup.2015.2.
Lang CL, Wang MH, Chiang CK, et al. Vitamin D and the immune system from the nephrologist’s point of view. IRSN Endocrinol. 2014. doi:10.1155/2014/10546.
Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol. 2005;60A(5):556–65.
Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254:78–101.
West CE, Jenmalm MC, Kozyrskyi AL, et al. The gut microbiota and inflammatory non communicable diseases : associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015;135(1):3–13. doi:10.1016/jaci.2014.11.012.
Lau WL, Kalantar-zadeh K, Vaziri ND. The gut as a source of inflammation in chronic kidney disease. Nephron. 2015;130:92–8. doi:10.1159/000381990.
Novati S, Sacchi P, Cima S, et al. General issues on microbial translocation in HIV-infected patients. Eur Rev Med Pharmacol Sci. 2015;19(5):866–78.
Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system : vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685–97. doi:10.103/nri2378.
Peelen E, Knioppenberg S, Muris AH, Thewissen M, Smolders J, Tervaert C, Hupperts R, Damoiseaux J. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev. 2011;10:733–43.
Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011;7:337–45.
Campbell GR, Spector SA. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog. 2012;8(11):e1003017.
Cantorna M, Waddell A. The vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci. 2014;1317:70–5.
Von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11:344–9.
Pace L, Tempez A, Arnold-Schrauf C, Lemaitre F, Bousso P, Felter L, et al. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science. 2012;338:532–6.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–9.
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled study. Am J Clin Nutr. 2006;83:754–9.
Hyppönen E, Berry D, Cortina-Borja M, Power C. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers : a cross sectional analysis in the 1958 British birth cohort. PLoS One. 2010;5(5):e10801.
Kuller LH, Tracy R, Belloso W, De Witt S, Dumond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203.
Mehta S, Hunter DJ, Mugusi FM, Spiegelman D, Manji KP, Giovanucci EL, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis. 2009;200:1022–30.
Viard JP, Souberbielle JC, Kirk O, Knysz B, Losso M, Gatell J, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS. 2011;25:1305–15.
Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, et al. Associations between 25-hydroxyvitamin D andimmunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons : the ANRS CO09 “COPANA” cohort study. PLoS One. 2013;8(9):e74868. doi:10.1371/journal.pone.0074868.
Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J, et al. Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons. J Infect Dis. 2014;210:234–43.
Fabre-Mersseman V, Tubiana R, Papagno L, Bayard C, Briceno O, Fastenackels S, et al. Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy. AIDS. 2014;28:2677–82.
Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis. Proc Natl Acad Sci U S A. 2012;109:15449–54.
van Tellingen A, Grooteman MP, Schoorl M, et al. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int. 2002;62:632–8.
Lim JH, Ravikumar S, Wang YM, Thamboo TP, Ong L, Chen J, et al. Bimodal influence of vitamin D in host response to systemic candida infection-vitamin D dose matters. J Infect Dis. 2015;212:635–44. pii: jiv033. [Epub ahead of print].
Lucas RM, Gorman S, Geldenhuys S, et al. Vitamin D and immunity. F1000Prime Rep. 2014;6:118. doi:10.12703/P6-118.
Assa A, Vong L, Pinnell LJ, et al. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210:12961305. doi:10.1093/infdis/jiu235.
Bacchetta J, Chun RF, Gales B, et al. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One. 2014;9(12):e116530. doi:10.137/journal.pone.0116530.
Bacchetta J, Sea JL, Chun RF, et al. FGF 23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res. 2013;28(1):46–55. doi:10.1002/jbmr.1740.
Chonchol M, Greene T, Zhang Y, et al. Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am Soc Nephrol. 2015. doi:10.1681/ASN.2014101009.
Zheng Z, Shi H, Jia J, et al. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol. 2013;14:199. doi:10.1186/1471-2369-14-199.
Mann MC, Hobbs AJ, Hemmelgarn BR, et al. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J. 2015;8:41–8. doi:10.1093/ckj/sfu122.
Palmer SC, Teixeira-Pinto A, Saglimbene V, et al. Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: a meta-analysis. Am J Kidney Dis. 2015. doi:10.1053/j.ajkd.2015.03.36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Viard, JP. (2016). Vitamin D Deficiency and Infection in Chronic Kidney Disease. In: Ureña Torres, P., Cozzolino, M., Vervloet, M. (eds) Vitamin D in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-32507-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-32507-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32505-7
Online ISBN: 978-3-319-32507-1
eBook Packages: MedicineMedicine (R0)